Indaptus Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
INDP on Nasdaq
Location
3 Columbus Circle, 15 Th Floor, New York, NY

There are no Buy or Sell transactions made by insiders since 12/7/2024

Indaptus Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Glen R. Anderson 10%+ Owner $2.79M Aug 10, 2023
Hoonmo Lee Director $1.63M Aug 4, 2021
Jeffrey Meckler Chief Executive Officer, Director $249K Jul 27, 2025
Boyan Litchev Chief Medical Officer $9.08K Feb 1, 2022
Roger J. Waltzman Chief Medical Officer $5.33K Oct 9, 2024
Michael Newman CSO and Director, Director, 10%+ Owner $5.33K Oct 9, 2024
Brian O'callaghan Director $976 Sep 30, 2022
Mark J. Gilbert Director $888 Jun 10, 2025
Robert Martell Director $888 Jun 10, 2025
William B. Hayes Director $0 Jun 10, 2025
Hila Karah Director $0 Jun 10, 2025
Roger Pomerantz Director $0 Jun 10, 2025
Anthony Maddaluna Director $0 Jun 10, 2025
Walt Linscott Chief Operating Officer $0 Apr 10, 2025
Nir Sassi Chief Financial Officer $0 Apr 10, 2025

Recent Insider Transactions by Companies or Individuals for Indaptus Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.